A Randomized, Double-Blind, Placebo-Controlled Study of Nab-Paclitaxel and Gemcitabine with or without SBP-101 in Subjects Previously Untreated for Metastatic Pancreatic Ductal Adenocarcinoma

Protocol No
PANBELA-CL-SBP-101-04
Phase
II/III
Summary

This project is being done to see if SBP-101 combined with nab-paclitaxel and gemcitabine works well to treat pancreatic adenocarcinoma.

Description
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer (ASPIRE)
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
Cancer, Pancreas/Liver, Gastrointestinal Cancers
ClinicalTrials.gov
go to website